Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (79,326)	$ (18,670)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,831	459
Amortization of costs capitalized to obtain contracts	2,419	3,164
Stock-based compensation expense	24,487	8,400
Compensation expense in connection with revesting notes (Note 7)	(100)	43
Noncash interest (income) expense, net	345	(18)
Convertible notes fair value adjustment	(1,875)	0
Derivative liability fair value adjustment	(1,183)	412
Gain on revaluation of contingent consideration	(5,279)	0
Noncash revenue from affiliate	(1,008)	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	16,412	(3,877)
Prepaid expenses and other assets	7,216	4,047
Inventory	(4,877)	(235)
Costs capitalized to obtain contracts, net	(2,777)	(1,382)
Accounts payable	(13,867)	2,196
Accrued expenses and other liabilities	(5,345)	3,652
Deferred revenue	2,410	2,344
Other noncurrent liabilities	620	(876)
Net cash used in operating activities	(54,897)	(341)
Cash Flows from Investing Activities:
Cash paid for acquisition, net of cash acquired	(113,401)	(2,983)
Internal use software	(701)	0
Cash advance on convertible note receivable	0	(4,000)
Net cash used in investing activities	(114,102)	(6,983)
Cash Flows from Financing Activities:
Proceeds from the exercise of options	1,994	2,223
Taxes paid related to net settlement of equity awards	(2,727)	(3,169)
Issuance of common stock	85	0
Proceeds from repayment of notes due from affiliates	648	0
Payments on borrowings	0	(53)
Repayment of convertible notes	(3,471)	0
Cash received in advance of the issuance of convertible notes	0	2,110
Net cash (used)/provided by financing activities	(3,471)	1,111
Net Decrease in Cash, Cash Equivalents, and Restricted Cash	(172,470)	(6,213)
Cash, Cash Equivalents and Restricted Cash at the Beginning of the Period	231,345	56,611
Cash, Cash Equivalents, and Restricted Cash at the End of the Period	58,875	50,398
Supplemental disclosure:
Cash paid during the period for taxes	0	(33)
Cash paid during the period for interest	(518)	0
Non-cash investing and financing activities:
Fair value of stock issued in connection with an acquisition	15,409	13,821
Fair value of convertible debt issued in connection with an acquisition	0	11,597
Fair value of contingent consideration issued in connection with an acquisition	0	5,900
Fair value of vested options assumed in connection with an acquisition	0	533
Forgiveness of convertible note receivable in connection an acquisition	0	4,023
Relative fair value of warrants issued with convertible debt	0	844
Beneficial conversion feature related to convertible debt	0	603
Fair value of bifurcated derivative related to convertible debt	0	663
Fair value of warrants held as investment in affiliate	5,474	0
Fair value of stock issued in settlement of contingent consideration	4,221	0
Total non-cash investing and financing activities:	25,104	37,984
Cash, cash equivalents and restricted cash
Cash and cash equivalents	43,964	50,050
Restricted cash	14,911	348
Total cash, cash equivalents, and restricted cash	$ 58,875	$ 50,398